IMO either there are either major problems finalising the exclusivity agreement (unlikely) or maybe it has been delayed by the goal posts having been moved. Could Sanofi be negotiating exclusivity for the Uniselect also.
I watched Alan speak at opening of nasdaq and heard him on Streetiq and there didnt appear to be hesitancy re the future of the Company - but also he didnt make any reference to the "imminent" signing.
This company's announcements in past 2 years have had a habit of coming from left field and I am hoping the next announcement will be a beauty.
Would like to see the commencement of manufacture of more production lines - we need all that new floor space filled as soon as possible.
Just my ramblings as I was certain the Sanofi agreement would have been announced on or around Nasdaq listing.
UNS Price at posting:
$1.39 Sentiment: Buy Disclosure: Held